AAV Gene Therapy QC
AAV capsid and transgene characterization
Commercial (RUO)Active
Key Facts
Indication
AAV capsid and transgene characterization
Phase
Commercial (RUO)
Status
Active
Company
About NanoMosaic
NanoMosaic is a Boston-based private biotech company founded in 2019, commercializing a novel photonics-based platform for multi-omic analysis. Its proprietary NanoNeedle technology, integrated into the 'Tessie' instrument and Nanoplate consumables, offers high-sensitivity, label-free detection with a simple ELISA-like workflow. The company is initially targeting the gene therapy quality control and neurodegenerative disease biomarker markets, positioning itself as a tool provider for research and diagnostic development.
View full company profile